Alle Storys
Folgen
Keine Story von Dr. Hönle AG mehr verpassen.

Dr. Hönle AG

euro adhoc: Dr. Hönle AG
Quarterly or Semiannual Financial Statements
Hönle Continues on Growth Course

Disclosure announcement transmitted by euro adhoc.
  The issuer is responsible for the content of this announcement.
14.02.2005
Hönle (ISIN: DE 000 515710 1), a leading systems provider of
industrial UV technology saw a successful start into the new year.
In the first quarter of 2004/2005, EUR 6.49 million in sales revenues
yielded operating profit (EBIT) of EUR 1.39 million. Compared to the
same quarter in the previous year, sales revenue was up by 33.7 % and
EBIT by 228.6 %. Earnings before tax (EBT) climbed from TEUR 540 to
EUR 1,545 million in the same period, and net income for the period
improved from TEUR 315 to TEUR 904. Relative to the 5.24 million of
Hönle shares, earnings per share rose from EUR 0.06 in the previous
year to EUR 0.17 in the current year.
The good development of business also contributed to an improvement
in the liquidity situation. Cash from ongoing business activities
rose by TEUR 825 in the first quarter, bringing the total cash
balance (cash and cash equivalents, investments, own shares) to EUR
18 million or EUR 3.44 per share.
Outlook:
UV technology continues to be a growth market, where the Hönle Group
has positioned itself well as a systems provider. Due to the high
share of project business, the company’s business development has
traditionally been characterized by quarterly fluctuations in
revenues and earnings. Hönle expects that second quarter revenues
will be below the previous year's level. Rising new orders at the
beginning of the second quarter give Management an optimistic outlook
for the future, however. The company’s goal will continue to be
further growth of revenue and earnings, with a focus on organic as
well as external growth.
end of announcement                    euro adhoc 14.02.2005 07:20:00 

Further inquiry note:

Peter Weinert
Tel.: +49 (0)89 856 08 173
E-Mail: peter.weinert@hoenle.de

Branche: Instrument Engineering
ISIN: DE0005157101
WKN: 515710
Index: Prime Standard, CDAX, Prime All Share, Technologie All Share
Börsen: Frankfurter Wertpapierbörse / regulated dealing
Berliner Wertpapierbörse / free trade
Hamburger Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Niedersächsische Börse zu Hannover / free trade
Bayerische Börse / free trade
Bremer Wertpapierbörse (BWB) / free trade

Weitere Storys: Dr. Hönle AG
Weitere Storys: Dr. Hönle AG